Semax — Nootropic Research Peptide

Description
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10), modified to enhance stability and activity in laboratory environments. It is widely studied for its interaction with neuroregulatory pathways, particularly those involved in cognitive function, neurotrophic signaling, and neurotransmitter modulation.

In controlled research settings, Semax is utilized in models exploring brain-derived neurotrophic factor (BDNF) expression, dopaminergic and serotonergic systems, and adaptive responses within the central nervous system. Its profile has made it a compound of interest in studies focused on neural signaling and cognitive-related pathways.

Semax continues to be examined for its role in supporting neurochemical balance and cellular responses within experimental neurological models.

Key Research Areas

• Neurotrophic signaling (BDNF-related pathways)
• Cognitive and memory-associated mechanisms
• Dopamine and serotonin pathway modulation
• Central nervous system regulation
• Neurochemical balance and adaptive responses

Specifications

Compound: Semax (ACTH 4–10 analog)
Peptide Class: Nootropic research peptide
Purity: ≥98% (HPLC)
Appearance: Lyophilized powder

Important Notice

This product is intended strictly for laboratory research purposes only.
Not for human consumption, medical use, or diagnostic applications.
Handling should be performed by qualified professionals in appropriate research environments.